Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,890 | 22,240 | 28,580 | 23,700 | 20,780 |
| Marketable Securities | 30,050 | 29,940 | 37,920 | 24,550 | 28,720 |
| Receivables | 48,930 | 51,780 | 69,980 | 43,170 | 44,730 |
| Inventories | 22,270 | 21,320 | 25,450 | 17,760 | 17,790 |
| Other current assets | 4,960 | 5,530 | 7,520 | 11,060 | 5,800 |
| TOTAL | $124,100 | $130,810 | $169,450 | $120,240 | $117,820 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 158,770 | 158,690 | 199,090 | 153,360 | 148,150 |
| TOTAL | $158,770 | $158,690 | $199,090 | $153,360 | $148,150 |
| Total Assets | $299,310 | $305,480 | $388,280 | $290,130 | $281,660 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 27,920 | 24,170 | 970 | 10,080 | 7,860 |
| Accounts payable and accrued liabilities | 42,720 | 44,110 | 61,300 | 41,740 | 42,810 |
| Other current liabilities | 0 | 1,180 | 4,090 | 2,120 | 2,250 |
| TOTAL | $75,650 | $75,430 | $73,610 | $60,030 | $62,070 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,880 | 24,370 | 78,720 | 32,700 | 34,770 |
| Other Non-Current Liabilities | 75,510 | 78,180 | 91,770 | 55,780 | 49,370 |
| TOTAL | $114,520 | $118,950 | $193,930 | $130,140 | $123,470 |
| Total Liabilities | $190,180 | $194,390 | $267,560 | $190,190 | $185,560 |
| Shareholders' Equity | |||||
| Common Shares | 165,910 | 157,180 | 192,670 | 157,240 | 148,530 |
| Retained earnings | -57,670 | -50,760 | -78,620 | -65,440 | -59,900 |
| Other shareholders' equity | -10,700 | 4,660 | 6,660 | 8,130 | 7,460 |
| TOTAL | $109,120 | $111,080 | $120,710 | $99,930 | $96,090 |
| Total Liabilities And Equity | $299,300 | $305,470 | $388,270 | $290,120 | $281,650 |